1. Home
  2. TECX vs MOV Comparison

TECX vs MOV Comparison

Compare TECX & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.91

Market Cap

545.3M

Sector

N/A

ML Signal

HOLD

Logo Movado Group Inc.

MOV

Movado Group Inc.

HOLD

Current Price

$26.50

Market Cap

568.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
MOV
Founded
2019
1961
Country
United States
United States
Employees
60
1386
Industry
Consumer Specialties
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
545.3M
568.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
MOV
Price
$30.91
$26.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$75.25
$31.50
AVG Volume (30 Days)
167.5K
172.2K
Earning Date
05-07-2026
05-28-2026
Dividend Yield
N/A
5.24%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.92
Revenue Next Year
N/A
$0.67
P/E Ratio
N/A
$25.52
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$12.90
52 Week High
$35.99
$26.93

Technical Indicators

Market Signals
Indicator
TECX
MOV
Relative Strength Index (RSI) 56.04 65.27
Support Level $17.71 $22.95
Resistance Level $32.27 N/A
Average True Range (ATR) 1.52 0.75
MACD -0.24 0.29
Stochastic Oscillator 68.80 89.38

Price Performance

Historical Comparison
TECX
MOV

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About MOV Movado Group Inc.

Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.

Share on Social Networks: